Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy (vol 23, 136, 2023)

dc.contributor.authorKaracin, C
dc.contributor.authorOksuzoglu, B
dc.contributor.authorDemirci, A
dc.contributor.authorKeskinkiliç, M
dc.contributor.authorBaytemür, NK
dc.contributor.authorYilmaz, F
dc.contributor.authorSelvi, O
dc.contributor.authorErdem, D
dc.contributor.authorAvsar, E
dc.contributor.authorPaksoy, N
dc.contributor.authorDemir, N
dc.contributor.authorGöksu, SS
dc.contributor.authorTürker, S
dc.contributor.authorBayram, E
dc.contributor.authorÇelebi, A
dc.contributor.authorYilmaz, H
dc.contributor.authorKuzu, ÖF
dc.contributor.authorKahraman, S
dc.contributor.authorGökmen, I
dc.contributor.authorSakin, A
dc.contributor.authorAlkan, A
dc.contributor.authorNayir, E
dc.contributor.authorUgrakli, M
dc.contributor.authorAcar, Ö
dc.contributor.authorErtürk, I
dc.contributor.authorDemir, H
dc.contributor.authorAslan, F
dc.contributor.authorSönmez, Ö
dc.contributor.authorKorkmaz, T
dc.contributor.authorCelayir, ÖM
dc.contributor.authorKaradag, I
dc.contributor.authorKayikçioglu, E
dc.contributor.authorSakalar, T
dc.contributor.authorÖktem, IN
dc.contributor.authorEren, T
dc.contributor.authorErul, E
dc.contributor.authorMocan, EE
dc.contributor.authorKalkan, Z
dc.contributor.authorYildirim, N
dc.contributor.authorErgün, Y
dc.contributor.authorAkagündüz, B
dc.contributor.authorKarakaya, S
dc.contributor.authorKut, E
dc.contributor.authorTeker, F
dc.contributor.authorDemirel, BÇ
dc.contributor.authorKaraboyun, K
dc.contributor.authorAlmuradova, E
dc.contributor.authorÜnal, OÜ
dc.contributor.authorOyman, A
dc.contributor.authorIsik, D
dc.contributor.authorOkutur, K
dc.contributor.authorÖztosun, B
dc.contributor.authorGülbagci, BB
dc.contributor.authorKalender, ME
dc.contributor.authorSahin, E
dc.contributor.authorSeyyar, M
dc.contributor.authorÖzdemir, Ö
dc.contributor.authorSelçukbiricik, F
dc.contributor.authorKanitez, M
dc.contributor.authorDede, I
dc.contributor.authorGümüs, M
dc.contributor.authorGökmen, E
dc.contributor.authorYaren, A
dc.contributor.authorMenekse, S
dc.contributor.authorEbinç, S
dc.contributor.authorAksoy, S
dc.contributor.authorImamoglu, GI
dc.contributor.authorAltinbas, M
dc.contributor.authorÇetin, B
dc.contributor.authorUluç, BO
dc.contributor.authorEr, Ö
dc.contributor.authorKaradurmus, N
dc.contributor.authorErdogan, AP
dc.contributor.authorArtaç, M
dc.contributor.authorTanriverdi, Ö
dc.contributor.authorÇiçin, I
dc.contributor.authorSendur, MAN
dc.contributor.authorOktay, E
dc.contributor.authorBayoglu, IV
dc.contributor.authorPaydas, S
dc.contributor.authorAydiner, A
dc.contributor.authorSalim, DK
dc.contributor.authorGeredeli, Ç
dc.contributor.authorYavuzsen, T
dc.contributor.authorDogan, M
dc.contributor.authorHacibekiroglu, I
dc.date.accessioned2024-07-18T12:08:41Z
dc.date.available2024-07-18T12:08:41Z
dc.identifier.other1471-2407
dc.identifier.urihttp://akademikarsiv.cbu.edu.tr:4000/handle/123456789/11040
dc.language.isoEnglish
dc.publisherBMC
dc.titleEfficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy (vol 23, 136, 2023)
dc.typeCorrection

Files